-
Je něco špatně v tomto záznamu ?
Pharmacological activation of mitochondrial BK(Ca) channels protects isolated cardiomyocytes against simulated reperfusion-induced injury
GH. Borchert, M. Hlaváčková, F. Kolář,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
ROAD: Directory of Open Access Scholarly Resources od 2001
Odkazy
PubMed
23576804
DOI
10.1177/1535370212474596
Knihovny.cz E-zdroje
- MeSH
- kardiomyocyty účinky léků fyziologie MeSH
- kardiovaskulární látky metabolismus MeSH
- krysa rodu rattus MeSH
- L-laktátdehydrogenasa analýza MeSH
- peroxid vodíku metabolismus MeSH
- potkani Wistar MeSH
- reperfuzní poškození myokardu patologie prevence a kontrola MeSH
- tetrazoly metabolismus MeSH
- thiomočovina analogy a deriváty metabolismus MeSH
- vápníkem aktivované draslíkové kanály s vysokou vodivostí - alfa-podjednotky agonisté metabolismus MeSH
- viabilita buněk účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The aim of this study was to find out whether opening of mitochondrial large-conductance Ca(2+)-activated potassium channels (BK(Ca)) protects cardiomyocytes against injury caused by simulated ischemia and reperfusion. This study also aimed to determine whether the protective mechanism involves signaling by reactive oxygen species (ROS) and phosphatidylinositol-3-kinase (PI3K). We used isolated ventricular myocytes, which are believed to contain no functional BK(Ca) channels in the sarcolemma. Cells were isolated from the left ventricles of adult male Wistar rats and subjected to 25-min metabolic inhibition with NaCN and 2-deoxyglucose followed by 30-min re-energization. NS11021 (0.1 μmol/L), a novel BK(Ca) channel opener, or hydrogen peroxide (2 μmol/L) added at re-energization, increased cell survival (the number of rod-shaped cells) and markedly reduced the release of lactate dehydrogenase (LDH). These cytoprotective effects of NS11021 were completely abolished by paxilline, a BK(Ca) inhibitor, or tempol, an antioxidant, but not by wortmannin, an inhibitor of PI3K. NS11021 slightly but significantly increased the fluorescence signal in 2'7'-dichlorodihydrofluorescein diacetate (DCF-DA)-loaded myocytes, indicating an increased ROS formation. The NS11021-induced ROS formation was abolished by paxilline or tempol. NS13558 (0.1 μmol/L), an inactive structural analogue of NS11021, affected neither cell survival/LDH release nor DCF-DA fluorescence. These results suggest that pharmacological activation of mitochondrial BK(Ca) channels effectively protects isolated cardiomyocytes against injury associated with simulated reperfusion. The mechanism for this form of protection requires ROS signaling, but not the activation of the PI3K pathway.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13023926
- 003
- CZ-PrNML
- 005
- 20130708112339.0
- 007
- ta
- 008
- 130703s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/1535370212474596 $2 doi
- 035 __
- $a (PubMed)23576804
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Borchert, Gudrun H $u Department of Developmental Cardiology, Institute of Physiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague, Czech Republic.
- 245 10
- $a Pharmacological activation of mitochondrial BK(Ca) channels protects isolated cardiomyocytes against simulated reperfusion-induced injury / $c GH. Borchert, M. Hlaváčková, F. Kolář,
- 520 9_
- $a The aim of this study was to find out whether opening of mitochondrial large-conductance Ca(2+)-activated potassium channels (BK(Ca)) protects cardiomyocytes against injury caused by simulated ischemia and reperfusion. This study also aimed to determine whether the protective mechanism involves signaling by reactive oxygen species (ROS) and phosphatidylinositol-3-kinase (PI3K). We used isolated ventricular myocytes, which are believed to contain no functional BK(Ca) channels in the sarcolemma. Cells were isolated from the left ventricles of adult male Wistar rats and subjected to 25-min metabolic inhibition with NaCN and 2-deoxyglucose followed by 30-min re-energization. NS11021 (0.1 μmol/L), a novel BK(Ca) channel opener, or hydrogen peroxide (2 μmol/L) added at re-energization, increased cell survival (the number of rod-shaped cells) and markedly reduced the release of lactate dehydrogenase (LDH). These cytoprotective effects of NS11021 were completely abolished by paxilline, a BK(Ca) inhibitor, or tempol, an antioxidant, but not by wortmannin, an inhibitor of PI3K. NS11021 slightly but significantly increased the fluorescence signal in 2'7'-dichlorodihydrofluorescein diacetate (DCF-DA)-loaded myocytes, indicating an increased ROS formation. The NS11021-induced ROS formation was abolished by paxilline or tempol. NS13558 (0.1 μmol/L), an inactive structural analogue of NS11021, affected neither cell survival/LDH release nor DCF-DA fluorescence. These results suggest that pharmacological activation of mitochondrial BK(Ca) channels effectively protects isolated cardiomyocytes against injury associated with simulated reperfusion. The mechanism for this form of protection requires ROS signaling, but not the activation of the PI3K pathway.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kardiovaskulární látky $x metabolismus $7 D002317
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a peroxid vodíku $x metabolismus $7 D006861
- 650 _2
- $a L-laktátdehydrogenasa $x analýza $7 D007770
- 650 _2
- $a vápníkem aktivované draslíkové kanály s vysokou vodivostí - alfa-podjednotky $x agonisté $x metabolismus $7 D051037
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a reperfuzní poškození myokardu $x patologie $x prevence a kontrola $7 D015428
- 650 _2
- $a kardiomyocyty $x účinky léků $x fyziologie $7 D032383
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a tetrazoly $x metabolismus $7 D013777
- 650 _2
- $a thiomočovina $x analogy a deriváty $x metabolismus $7 D013890
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hlaváčková, Markéta $u -
- 700 1_
- $a Kolář, František $u -
- 773 0_
- $w MED00005629 $t Experimental biology and medicine (Maywood, N.J.) $x 1535-3699 $g Roč. 238, č. 2 (2013), s. 233-41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23576804 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130708112801 $b ABA008
- 999 __
- $a ok $b bmc $g 987606 $s 822306
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 238 $c 2 $d 233-41 $i 1535-3699 $m Experimental biology and medicine $n Exp Biol Med (Maywood) $x MED00005629
- LZP __
- $a Pubmed-20130703